Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Kanagawa Cancer Center, Kanagawa, Japan

1 abstract

Abstract
Palbociclib (P) plus tamoxifen (TAM) ± goserelin in women with hormone receptor-positive (HR+)/HER2-negative (HER2−) advanced breast cancer (ABC): Primary results of NCCH1607/PATHWAY, an Asian international double-blind randomized phase 3 trial.
Org: National Cancer Center Hospital East, Chiba, Japan, National Cancer Center Hospital, Tokyo, Japan, Kanagawa Cancer Center, Kanagawa, Japan, Chiba Cancer Center, Chiba, Japan, Koo Foundation Sun Yat-sen Cancer Center, Taipei, Taiwan,